EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of respiratory pathogens among hospitalised patients with acute respiratory infection during and after the COVID-19 pandemic in Shijiazhuang, China

Pan-Pan Zheng, Ya-Nan Zhao, Zhi-Kai Wang, Min-Zhen Wang, Rong Li, Jing Zhang, Nan Li, Zi-Feng Zhang, Rui-Juan Rong, Yi-Chan Sun, Zan-Chao Liu

Frontiers in Cellular and Infection Microbiology · 28.11.2024 · 14

DOI: 10.3389/fcimb.2024.1486953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 28.11.2024. Verfasst von Pan-Pan Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Basic Medicine for Diabetes, Shijiazhuang Second Hospital, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: COVID-19, Respiratory Tract Infections, SARS-CoV-2, Hospitalization. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic and the resulting non-pharmaceutical interventions (NPIs) have led to changes in the epidemiology of other respiratory pathogens. This study was conducted to explore the epidemiological characteristics of 13 respiratory pathogens, including 11 respiratory viruses and 2 non-classical microorganisms, in hospitalised patients with acute respiratory tract infections (ARTIs) and to compare the prevalence of respiratory pathogens during and after the COVID-19 pandemic.

Methods

We conducted a single-centre retrospective study involving 8979 patients with ARTIs in Shijiazhuang City from December 2019 to December 2023. The GeXP analysis platform and multiple reverse transcription–PCR (mRT–PCR) technology were used to simultaneously detect 13 respiratory pathogens. The ARIMA model was constructed to predict the pathogen detection rate in each quarter of Shijiazhuang City in the next 2 y.

Results

Among the 8979 patients, 4169 (46.43%) tested positive for respiratory pathogens. The total pathogen detection rate rebounded in the year after the COVID-19 pandemic. After the COVID-19 pandemic, the positive rates in men were slightly higher than those in women and the positive rates in spring and winter were significantly higher than those in summer. The dominant pathogens during the COVID-19 pandemic were Influenza A viru (InfA; 24.08%) and Human Rhinovirus (HRV; 21.77%), and after the COVID-19 pandemic were InfA (27.92%) and H3 (21.17%). During the COVID-19 pandemic, InfA and HRV frequently occurred in all age groups. After the COVID-19 pandemic, InfA and Seasonal Influenza virus H3N2 (H3) frequently occurred in all age groups.

Conclusions

A series of NPIs introduced by the Chinese government during the COVID-19 pandemic had a significant impact on acute upper respiratory pathogenic infections. After the withdrawal of the NPIs, the spectrum of respiratory pathogens changed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Tract InfectionsSARS-CoV-2HospitalizationHumansChinaMaleFemaleMiddle AgedAdultRetrospective StudiesAgedPrevalenceYoung AdultAdolescentChild, PreschoolChildInfantAged, 80 and overSeasonsPandemicsInfant, Newborn

Stichwörter der Autor:innen

ARTIs/ILICOVID-19epidemiologynon-classical microorganismsrespiratory pathogens

Autor:innen und Institutionen

  • Hebei Key Laboratory of Basic Medicine for Diabetes, Shijiazhuang Second Hospital, Shijiazhuang, Hebei, China.
  • Shijiazhuang Technology Innovation Center of Precision Medicine for Diabetes, Shijiazhuang Second Hospital, Shijiazhuang, Hebei, China.
  • School of Clinical Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
  • Institute of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou, Gansu, China.

Zitieren

APA

Zheng, P. P., Zhao, Y. N., Wang, Z. K., Wang, M. Z., Li, R., Zhang, J., Li, N., Zhang, Z. F., Rong, R. J., Sun, Y. C., & Liu, Z. C. (2024). Prevalence of respiratory pathogens among hospitalised patients with acute respiratory infection during and after the COVID-19 pandemic in Shijiazhuang, China. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1486953

Vancouver

Zheng PP, Zhao YN, Wang ZK, Wang MZ, Li R, Zhang J, et al. Prevalence of respiratory pathogens among hospitalised patients with acute respiratory infection during and after the COVID-19 pandemic in Shijiazhuang, China. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1486953

BibTeX
@article{Zheng2024,
  author = {Zheng, Pan-Pan and Zhao, Ya-Nan and Wang, Zhi-Kai and Wang, Min-Zhen and Li, Rong and Zhang, Jing and Li, Nan and Zhang, Zi-Feng and Rong, Rui-Juan and Sun, Yi-Chan and Liu, Zan-Chao},
  title = {Prevalence of respiratory pathogens among hospitalised patients with acute respiratory infection during and after the COVID-19 pandemic in Shijiazhuang, China},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1486953}
}
Kostenlos starten →